Theme: Metabolomics:Recent trends and future challenges
Metabolomics Congress 2019
Conference Series LLC LTD invites you to the 15th International Conference and Exhibition on Metabolomics & Systems Biology during April 29-30, 2019, Kyoto Japan. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world-class Scientists.
Metabolomics Congress 2019 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more.
Conference is attracting academicians including Professors, PhD Scholars, Students, Pharmaceutical Industrial Giants, Toxicology Societies and the people Associated, Nobel laureates in Health Care and Medicine, Life science experts, Pharmaceutical companies, Clinical Laboratories and Technicians, Bioinformatics Professionals, Research Institutes and members, Supply Chain Companies, Manufacturing Companies, Training Institutes, Business Entrepreneurs.
Metabolomics congress 2019 will be underlined by the presence of academicians including metabolomics educators, postgraduates, affiliations, Industrial Giants, Business Entrepreneurs etc. This meeting comprises brief Keynote presentations, Speaker talks, Exhibition, Symposia, and Workshops.
The conference will be the perfect platform for:
- Honorable scientific talks by the global scientific community
- Sterling workshop sessions
- Awards and Global Recognition to meritorious Researchers
- Global Networking opportunities with 50+ Countries
- Novel Techniques to Benefit Your Research
- Exquisite Platform for showcasing your products and International Sponsorship
- Poster - paper presentations and world-class exhibitions
- Opportunities to gain a deeper understanding of the topic
- Meet Academics and Industrial professionals to get inspired
- Great credits for the work in progress
- Valuable talks and symposiums from renowned speakers
- Meaningful sessions and accomplishments
Conference Series LLc LTD and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Conference Series LLc LTD 15th International Conference and Exhibition on Metabolomics & Systems Biology during April 29-30, 2019, Kyoto Japan. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.
Metabolomics Congress 2019 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of enthusiasm to doctors in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. Metabolomics as an order makes utilization of systematic procedures, for example, spectroscopy, chromatography, and multivariable investigation. Metabolomics permits researchers to gauge physiological impacts and to screen for unfavorable responses to tranquilizes.
Conference Highlights
- 200+ Participation (70% Industry: 30% Academia)
- 5+ Keynote Speakers
- 50+ Plenary Speakers
- 5+ Exhibitors
- 10 Innovative Educational Sessions
- 5+ Workshops
- B2B Meetings
Benefits of Attending the Conference:
- Learn new ideas for serving clients
- Gain inspiration
- Engage your mind and enrich your heart with new insights
- Discover how advances in the health sector are impacting globally
- Share experiences, insights and strategies in interactive peer-to peer round tables and much more
Biochemistry Conferences 2019 is delighted to welcome each one of the individuals to the "Metabolomics congress 2019" amidst April 29-April 30, 2019, at Kyoto, Japan which provide a forum for an exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field.
Metabolomics congress 2019 will be underlined by the presence of academicians including metabolomics educators, postgraduates, affiliations, Industrial Giants, Business Entrepreneurs etc. This meeting comprises brief Keynote presentations, Speaker talks, Exhibition, Symposia, and Workshops.
Theme: Metabolomics: Recent trends and future challenges
Track 1: Cancer Therapeutic Approaches
Cancer biomarkers have many potential applications in cancer treatment, including screening, diagnosis, risk assessment, prediction of response to treatment, and monitoring of progression of disease. Metabolomics is growing in the field with particular attention to its application as a biomarker in cancer diagnosis. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, lipids, proteins, sugars, and little metabolites, nucleic acid, cytokinetic and cytogenetic parameters etc.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 2: Metabolic Syndrome
Metabolic syndrome in short words can be explained as a group of conditions which includes increased blood pressure, abnormal cholesterol, high blood sugar, excess body fat around the waist and or triglyceride levels, that occur together and increase your risk of heart disease, diabetes, and stroke. Most of the disorders associated with metabolic syndrome have no symptoms, although it is closely linked to overweight or obesity, insulin resistance, and inactivity. Recent researches proved that prolonged chronic stress can be a cause for metabolic syndrome by disrupting the hormonal balance of the hypothalamic-pituitary-adrenal axis. Metabolic syndrome can be prevented or reversed by adopting a few numbers of lifestyle changes, including losing weight, regular exercise, a healthy diet, stopping smoking, and cutting down on alcohol.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 3: Therapeutic Metabolomics
Metabolomics had profound importance in recent years in context to its applications in the field of drug development and drug discovery. With recent advances in the field of metabolomics, it can be proved as a major tool for innovative therapeutic discoveries. Metabolites have non-invading nature and close relation to the phenotype. That makes it a perfect tool for the pharmaceutical, agricultural industries, and preventive healthcare among others. In the agricultural/chemical industry, metabolomics may be used to develop pesticides and herbicides. With increasing importance being placed on health and safety related aspects of our food, metabolomics can potentially be a valuable tool in quality control and food processing, or in plant breeding for improved crop varieties and in the development of novel foodstuffs Centre for Metabolomics is associated with therapeutic metabolomics. Computational immunology is a field of science that incorporates high-throughput genomic and bioinformatics ways to deal with immunology.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 4: Plant & Environmental Metabolomics
Metabolomics is the study of exogenous and endogenous low atomic mass metabolites inside of a cell, tissue, or bio fluid of a life form. The sub-control of environmental metabolomics is the utilization of metabolomics strategies to investigate the connections of life forms with their surroundings. Plant Metabolomics deals with the evaluation of plant framework at the sub-atomic level giving a non-one-sided characterization of the total metabolite pool (metabolome) of plants under particular conditions whereas environmental metabolomics is the utilization of strategies to find out the relationship between life forms with their surroundings.
Using Metabolomics, a better understanding of the correlation between biochemical composition and genes of plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totaling about $12 million (about Yen 960 million) to grow new indeed well-disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 5: Obesity and Bariatric Surgery
Obesity has become a global health problem that contributes to numerous life-threatening and disabling diseases, such as type 2 diabetes mellitus and coronary artery disease. The long-term results of traditional weight loss therapies, including diet, exercise, and medications, are relatively poor. Bariatric surgery is the most effective treatment of morbidly obese patients to allow substantial, sustained weight loss and to improve or resolve obesity-associated comorbidities, thereby reducing mortality.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 6: Metabolic Modelling and Synthetic Biology
Synthetic biology main purposes are to create novel biological functions and systems by combining biology with engineering. The workflow of the development of novel biological functions with synthetic biology is ideally linear which will be attainable with the quantitative engineering approach, high-quality predictive models, and libraries of well-characterized parts. In particular phases of synthetic biology workflow different types of metabolic models, mathematical representations of metabolism and its components, enzymes and metabolites are useful.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 7: Proteomics in medicine
Molecular Medicine stimulates the reflective of the biological mechanism of disease at the cellular and molecular levels for enhanced treatment, prevention and diagnoses of disease. Proteomics plays a vital role in molecular medicine and medical research, such as in diagnostics and drug discovery, because of the connection between genes, proteins, and diseases. It is considered to be the next step in modern biology. Proteomics is dynamic compared to genomics because it changes constantly to reflect the cell’s environment. The main objectives in the area of proteomics are; identifying all proteins in different samples and analyze differential protein expression, characterize proteins by studying and identifying their function, recognize protein interaction network and cellular localization. Cancer biologists have made the first attempts to utilize proteomics for prognostic and diagnostic purposes. Recently developed serum-based proteomic pattern diagnostics, which is a new method of diagnosis and disease identification for ovarian cancer detection.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 8: Transcriptomics & Metabolic pathways
Transcriptomic studies deals with the measurement of simultaneous expression of up to thousands of genes and can be used to identify which genes are down or up regulated under certain conditions. Metabolic pathway is a series of concoction responses occurring inside a cell. In a pathway metabolite, the beginning compound is changed by an arrangement of synthetic responses. These responses are catalyzed by enzymes. These chemicals frequently require dietary minerals, vitamins, and different cofactors to work. Metabolic pathways are classified as anabolic and catabolic pathways.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 9: Food & Nutritional Metabolomics
Nutritional metabolomics is using chemical profiling of small molecule to support the assimilation of nutrition and diet in complex Biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Food-omics derived from the digestion and biotransformation of foods and their constituents in which MS techniques are considered indispensable.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 10: Frontiers of Metabolomics Research
Metabolomics studies can provoke enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for the solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower and drive the use of computational approaches to manage the examination of biomedical and disease frames.
New programming and progressively complex NMR metabolite spectral databases are inducing the fascinating limits of NMR spectroscopy to perceive and assess little particles in the answer for examinations of metabolite biomarkers and metabolic flux. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to gauge a more extensive cluster of little particle metabolites.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 11: Metabolomics in Precision Medicine
Precision medicine is rapidly developing tool for medical treatment to a small group or even individual patients based on their genetics, lifestyle and environment. It relies heavily on developments in systems biology and Metabolomics disciplines, including metabolomics. While a few advances in prescription have been made, the practice is not as of now being used for most diseases.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 12: Clinical Metabolomics & Lipidomics
Clinical metabolomics involves the application of clinical laboratory protocols, standards, and oversight of a global biochemical profiling technology whose results are interpreted relative to a reference adherent. The inevitable role of lipids in cell, tissue and organ physiology is explained by a large number of genetic studies and by many human diseases that involve the blockage of lipid metabolic enzymes and pathways. Examples of such diseases include diabetes, cancer as well as infectious diseases and neurodegenerative diseases. Within metabolomics, lipidomics has its own identity. Analytical approaches such as LC and MS for system-level analysis of lipids and their interacting partners now make this field a promising area of biomedical research, with a variety of applications in drug and biomarker development.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 13: Data Analysis & Systems Biology
Systems biology is a field within biology aimed at understanding biological processes at the systems level and developing from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines.
Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, stated not long ago that it would build up two new divisions including one focused on biomedical innovation, bioinformatics, and computational biology as part of a reorganization that contains the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of ancillary scientific computing.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, oteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 14: Enhancing Analytical Approaches
The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for numerous orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capability to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy has risen as a standout amongst the most powerful diagnostic systems in metabolomics.
Metabolon, Agilent Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main frontrunners in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to impel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 15: Analytical Platforms in Metabolomics
Metabolomics is the subjective and quantitative investigation of small particles such as thiols, lipids, amino acids, nucleic acids, vitamins, peptides, natural acids and starches etc. The current advancement of diagnostic stages such as UPLC, GC, HPLC, CE coupled to MS and NMR spectroscopy empowers measurement, partition, portrayal, discovery and of these metabolites and other related metabolic pathways.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, oteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Track 16: Metabolomics devices
Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomics research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex. Bruker, AB SCIEX, and Thermo Fisher likewise offer instruments for imaging MS, additionally called MALDI imaging.
Related Societies and Associations:
American association for the advancement of science, American association for cancer research, American association of pharmaceutical scientists, Association for Consumer Research (ACR), American cancer society, Bioinformatics society of India, Nutrigenomics Organization. The British Society for Genetic Medicine, The Genetics Society, Netherlands metabolomics center, The Australian biotechnology association, Human Proteome Organization, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Clinical Genetics Society.
Relevant Metabolomics Conferences | Biochemistry Conferences | Bioinformatics Conference
Summary:
Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, Proteomics, Systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic Profiling, clinical metabolomics, Translational Sciences, Mass Spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.
'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.
Importance & Scope:
Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.
The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Centre for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.
Why Kyoto, Japan ?
Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013 . By 2018, the market is expected to grow to $ 53.8 Billion.
The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe
The Japanese market is a promising region for metabolomics companies, as a high amount of metabolomics research is being conducted in the country.
Global Life science Market Share by Country
Why to attend ???
Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.
Major Metabolomics Related Associations around the Globe :
- Metabolomics Society
- American association for the advancement of science
- American association for clinical chemistry
- American association for cancer research
- American association of pharmaceutical scientists
- Association for Consumer Research (ACR)
- American cancer society
- Bioinformatics society of India
- Nutrigenomics Organization
- The British Society for Genetic Medicine
- The Genetics Society
- Netherlands metabolomics center
- The Australian biotechnology association
- Human Proteome Organization
- Indiana Proteomics Consortium
- Proteome Society
- European federation of biotechnology
- Australasian Proteomics Society
- Clinical Genetics Society
Major Metabolomics Related Research Units in Japan :
- RIKEN Center for Sustainable Resource Science
- Institute for Advanced Biosciences, Keio University
- Human Metabolome Technologies
- Osaka University
- University of Tokyo
- Kyoto University
- University of Tsukuba
- Nagoya University
- Hokkaido University
- University of Tsukuba
Target Audience:
Directors/Managers & Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies.
Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.
Glance at Market of Metabolomics:
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.
In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.
The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.
Statistics which shows growth in importance of Metabolomics :
Metabolomics Market Worth $2, 100 Million by 2019 - New Report by Markets and Markets.
Statistics of Industries Associated with Metabolomics :
North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.
The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).
Fund Allotment towards Metabolomics Research :
The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.
These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.
NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.
- Michigan Regional Comprehensive Metabolomics Resource Core (MRC2)
- NIH West Coast Metabolomics Center at UC Davis
- Southeast Center for Integrated Metabolomics (SECIM)
- Metabolomics Core at Mayo Clinic
- Research Center for Stable Isotope Resolved Metabolomics
Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.
Metabolomic Diagnostics is engaged in a study called IMPROvED, which has received €6m in European FP7 funding.
Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years.
Conference Highlights
- Cancer Therapeutic Approaches
- Metabolic Syndrome
- Metabolomics in Precision Medicine
- Frontiers of Metabolomics Research
- Therapeutic Metabolomics
- Transcriptomics & Metabolic pathways
- Metabolic Modelling and Synthetic Biology
- Clinical Metabolomics & Lipidomics
- Plant & Environmental Metabolomics
- Food & Nutritional Metabolomics
- Metabolomic devices
- Analytical Platforms in Metabolomics
- Data Analysis & Systems Biology
- Enhancing Analytical Approaches
- Obesity and Bariatric Surgery
- Proteomics in Medicine
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | April 29-30, 2019 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | Day 1 | Day 2 | |
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by